LDH-IN-5

LDH-IN-5 is a Lactate Dehydrogenase (LDH) inhibitor with neuroprotective activity. LDH-IN-5 can inhibit cell apoptosis, reduce ROS, MDA production and increases superoxide dismutase (SOD) activity. LDH-IN-5 can be used for the research of neurological disease, such as ischemic stroke[1].

Product Specifications

CAS Number

[2768522-31-0]

UNSPSC

12352005

Target

Apoptosis; Lactate Dehydrogenase; Reactive Oxygen Species (ROS) ; SOD

Related Pathways

Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Field of Research

Neurological Disease

Smiles

CC1(C)[C@@]2(C)[C@H](OC(CCC(O[C@H](C3=CC=C(Br)C=C3C(O[C@H]4[C@@](C5(C)C)(C)CC[C@H]5C4)=O)CCCC)=O)=O)C[C@@H]1CC2

Molecular Formula

C36H51BrO6

Molecular Weight

659.69

References & Citations

[1]Wang X, et al. Design, synthesis and evaluation of NBP/borneol hybrids as neuroprotective agents for the treatment of ischemic stroke. Bioorg Chem. 2025 Oct;165:109056.